Harte-Hanks revamps digital practice

Share this article:
Harte-Hanks' Glen Hartman
Harte-Hanks' Glen Hartman

Harte-Hanks has announced a series of changes and promotions as it enhances its digital practice area.

Glen Hartman has been promoted to managing director of the digital practice.

Previously, Hartman led Harte-Hanks as an SVP for digital marketing for data-based marketing solutions. In his new role, Hartman is responsible for managing all aspects of the digital practice and its offerings including web site development, online advertising, search engine marketing, e-mail, mobile messaging, Web analytics and social networking.

In addition, the digital practice has added to its management team with several new hires. These hires include Julie Donovan, VP/practice leader, digital media; Thomas Molitor, VP/practice leader, digital interaction; Gary Druckenmiller Jr., VP, strategy & business development, digital practice.

“The Harte-Hanks digital practice has grown considerably throughout the past year,” Frank Harvey, corporate officer and VP said in a statement. “While this growth represents the increasing importance of digital media and marketing, it also represents the value of our digital expertise including the understanding we provide to our clients about how digital applications and their successful executions feed a larger multichannel strategy.”

Share this article:

Email Newsletters

More in News

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?

In sunny world of LASIK marketers, a dark underbelly

In sunny world of LASIK marketers, a dark ...

Last week, the former FDA branch chief who originally approved LASIK machines asked FDA to reconsider its denial last month of his petition to ban these devices.

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.